These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34508657)

  • 1. CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria.
    Ke J; Robinson D; Wu ZY; Kuftin A; Louie K; Kosina S; Northen T; Cheng JF; Yoshikuni Y
    Cell Chem Biol; 2022 Apr; 29(4):696-710.e4. PubMed ID: 34508657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria.
    Wang G; Zhao Z; Ke J; Engel Y; Shi YM; Robinson D; Bingol K; Zhang Z; Bowen B; Louie K; Wang B; Evans R; Miyamoto Y; Cheng K; Kosina S; De Raad M; Silva L; Luhrs A; Lubbe A; Hoyt DW; Francavilla C; Otani H; Deutsch S; Washton NM; Rubin EM; Mouncey NJ; Visel A; Northen T; Cheng JF; Bode HB; Yoshikuni Y
    Nat Microbiol; 2019 Dec; 4(12):2498-2510. PubMed ID: 31611640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE.
    Ke J; Zhao Z; Coates CR; Hadjithomas M; Kuftin A; Louie K; Weller D; Thomashow L; Mouncey NJ; Northen TR; Yoshikuni Y
    Metab Eng; 2022 Jan; 69():188-197. PubMed ID: 34890798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal integration of complex DNA constructs using CRAGE and CRAGE-Duet systems.
    Zhao Z; Cheng JF; Yoshikuni Y
    STAR Protoc; 2022 Sep; 3(3):101546. PubMed ID: 35842866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CRISPR/Cas9 Cleavage System for Capturing Fungal Secondary Metabolite Gene Clusters.
    Xu X; Feng J; Zhang P; Fan J; Yin WB
    J Microbiol Biotechnol; 2021 Jan; 31(1):8-15. PubMed ID: 33144546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed CRISPR/Cas9- and TAR-Mediated Promoter Engineering of Natural Product Biosynthetic Gene Clusters in Yeast.
    Kang HS; Charlop-Powers Z; Brady SF
    ACS Synth Biol; 2016 Sep; 5(9):1002-10. PubMed ID: 27197732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic toolbox for Photorhabdus and Xenorhabdus: pSEVA based heterologous expression systems and CRISPR/Cpf1 based genome editing for rapid natural product profiling.
    Rill A; Zhao L; Bode HB
    Microb Cell Fact; 2024 Apr; 23(1):98. PubMed ID: 38561780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mpCRISTAR: Multiple Plasmid Approach for CRISPR/Cas9 and TAR-Mediated Multiplexed Refactoring of Natural Product Biosynthetic Gene Clusters.
    Kim H; Ji CH; Je HW; Kim JP; Kang HS
    ACS Synth Biol; 2020 Jan; 9(1):175-180. PubMed ID: 31800222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
    Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
    ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Mediated Activation of Biosynthetic Gene Clusters for Bioactive Molecule Discovery in Filamentous Fungi.
    Roux I; Woodcraft C; Hu J; Wolters R; Gilchrist CLM; Chooi YH
    ACS Synth Biol; 2020 Jul; 9(7):1843-1854. PubMed ID: 32526136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of CRISPR/Cas9 technology in sepsis research.
    Wu M; Hu N; Du X; Wei J
    Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems Analysis of Highly Multiplexed CRISPR-Base Editing in Streptomycetes.
    Whitford CM; Gren T; Palazzotto E; Lee SY; Tong Y; Weber T
    ACS Synth Biol; 2023 Aug; 12(8):2353-2366. PubMed ID: 37402223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.